First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study

European Journal of Cancer

Volumn 37, Issue 15, 2001, Pages 1833-1838

  Papakostas, P ^a   Kouroussis, Ch ^b   Androulakis, N ^b   Samelis, G ^a   Aravantinos, G ^c   Kalbakis, K ^b   Sarra, E ^b   Souglakos, J ^b   Kakolyris, S ^b   Georgoulias, V ^b  

^a HIPPOKRATION HOSPITAL   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c AGII ANARGIRI CANCER HOSPITAL   (Greece)

Author keywords

Biliary tract carcinoma; Chemotherapy; Docetaxel

Indexed keywords

ANTIEMETIC AGENT; CIMETIDINE; DEXAMETHASONE; DOCETAXEL;

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; GRANULOCYTOPENIA; HUMAN; LONG TERM CARE; MALE; METASTASIS; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BILIARY TRACT NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PATIENT COMPLIANCE; SURVIVAL RATE; TAXOIDS; TREATMENT OUTCOME;

EID: 0034813260     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00214-3     Document Type: Article

References (18)

1. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma
2. Adenocarcinomas of stomach, pancreas, liver and biliary tracts: Survival of 328 patients treated with fluoropyrimidine therapy
3. Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma
4. Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer
5. Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer - An updated overview
6. Overview of docetaxel (Taxotere) in the treatment of non-small-cell lung cancer
7. Docetaxel (taxotere)-cisplatin (TC): An effective drug combination in gastric cancer
8. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer
9. A phase II study of cisplatin in patients with biliary tract carcinoma
10. Phase II trial of gemcitabine (GEM) in biliary tract cancers (BTC)
11. 5-Fluorouracil, mitomycin and doxorubicin (FAM) in carcinoma of the biliary tract
12. Epirubicin-sequential methotrexate biliary system. A phase II study
13. Phase II trial of intravenous fluorouracil and subcutaneous interferon alpha-2b for biliary tract cancer
14. Phase II trial of cisplatin, epirubicin and continious infusion 5-fluorouracil (5-FU) (CEF therapy) for advanced gallbladder cancer
15. Cisplatin, epirubicin and fluorouracil (PEF) for advanced biliary tract carcinoma
16. Phase II study of paclitaxel therapy for unresectable biliary tree carcinoma
17. A phase I and pharmacokinetic study of docetaxel in patients with liver metastases with or without impaired liver function due to malignances